LABORATORIOS FARMACEUTICOS ROVI, S.A. «...1112131415...» Page 11 out of 17 from 01/07/1988 to 09/10/2015 The price-sensitive information presented in other languages is a literal translation of the price-sensitive information stated in Spanish 29/07/2010 07:46 LABORATORIOS FARMACEUTICOS ROVI, S.A. Information on P&L The Company releases the press release related to the 2010 first half results Register number: 128642 29/07/2010 07:42 LABORATORIOS FARMACEUTICOS ROVI, S.A. Interim financial information La sociedad remite información sobre los resultados del primer semestre de 2010 Register number: 128641 05/07/2010 08:55 LABORATORIOS FARMACEUTICOS ROVI, S.A. Information on dividends La Sociedad remite información sobre el pago de dividendo. Register number: 127563 16/06/2010 14:35 LABORATORIOS FARMACEUTICOS ROVI, S.A. Announcements and resolutions of general shareholders meetings La Sociedad informa sobre la celebración de su Junta General de Accionistas. Register number: 126687 10/05/2010 07:45 LABORATORIOS FARMACEUTICOS ROVI, S.A. R&D: new licenses, patents and registered trademarks The Company announces the results from the phase III clinical trials for Bemiparin on diabetic foot ulcers Register number: 125021 06/05/2010 08:28 LABORATORIOS FARMACEUTICOS ROVI, S.A. Announcements and resolutions of general shareholders meetings La Sociedad informa sobre la convocatoria de su Junta General de Accionistas Register number: 124851 06/05/2010 07:45 LABORATORIOS FARMACEUTICOS ROVI, S.A. Interim financial information La sociedad remite información sobre los resultados del primer trimestre de 2010 Register number: 124847 24/04/2010 15:55 LABORATORIOS FARMACEUTICOS ROVI, S.A. R&D: new licenses, patents and registered trademarks The Company announces the results of an interim analysis of the Phase II "ABEL" clinical trial of Bemiparin in small cell lung cancer. Register number: 124043 26/03/2010 13:49 LABORATORIOS FARMACEUTICOS ROVI, S.A. Strategic agreements with third parties The company announces the implementation of the strategic pharmaceutical agreement for marketing and manufacturing reached by ROVI and MSD. Register number: 122865 25/03/2010 19:02 LABORATORIOS FARMACEUTICOS ROVI, S.A. Strategic agreements with third parties The Company publishes the press release related to the signature of a letter of intentions for the production of vaccines for seasonal and pandemic flu Register number: 122785 Page 11 out of 17 «...1112131415...»